Entos combines machine learning and automated chemistry to revolutionize small-molecule therapeutics design.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $53M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 15.07.2021 | Sequoia Ca... | sequoiacap... |
| - | OrbiMed | orbimed.co... |
| - | Freeflow V... | freeflow.i... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.07.2021 | Series A | $53M | - |
Mentions in press and media 15
| Date | Title | Description |
| 09.11.2021 | Mega Factor: Three Forces Fuse for Computing's Million-X Leap | Researchers are finding the jet fuel for the million-x advances their work now demands. They face rising mountains of data with soaring computational requirements they can't surmount relying solely on Moore's law, the sputtering combustion ... |
| 20.07.2021 | Digital health news, funding roundup in the prior week; July 18 | With $150B already invested, VC is set to have another recording breaking year With $150B already invested, VC is set to have another recording breaking year. There was $75 billion invested across an estimated 4,302 deals in the second quar... |
| 16.07.2021 | StartUPDATES: New developments from healthcare startups | HealthMine EVP of Growth Kent Holdcroft recently presented at a Strategic Solutions Network event for Medicare Stars, HEDIS, Quality & Risk. Kent’s presentation addresses how Medicare Advantage plans can use technology to create a perso... |
| 15.07.2021 | Entos picks up $53M | Entos has raised a $53 million Series A co-led by Coatue and Catalio Capital Management. The San Diego-based company uses AI and automated synthetic development to design small-molecule therapeutics. Founded in 2019, Entos was valued at $11... |
| 14.07.2021 | Daily funding roundup - July 14th, 2021 | Pantheon raised $100M; Ribon Therapeutics landed $65M; Cardless secured $40M DevRev: DevRev is a Bay Area-based software company from two former Nutanix executives that aims to bring the coding and revenue processes closer together. DevRev ... |
| 14.07.2021 | Entos Raises $53 Million Series A Round Led by Coatue and Catalio | Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, today announced the closing of a $53 million Series A fi... |
| 14.07.2021 | Entos collects $53M to bring quantum tech to AI drug design Are Real-time Gene Therapy Results Possible? | The advent of artificial intelligence and machine learning already promises to shave months to years off of the typical drug discovery timeline—but why stop there? Entos believes it can make the process even faster while using fewer data re... |
| 14.07.2021 | Venture capital exit activity hits a record | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content How an operational overhaul led this company to success From RPM International If it... |
| 14.07.2021 | Venture capital exit activity hits a record | If it feels as if venture capitalists across the board are congratulating each other on the daily for an initial public offering or acquisition of a portfolio company, you’re not wrong. Paid Content How to ensure your marketers stay dynamic... |
| 14.07.2021 | Entos Raises $53M in Series A Funding | Entos, Inc., a San Diego, CA-based creator of a platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, closed a $53m Series A financing. The round was led by Coatue and Catalio Cap... |
Show more